Seacoast Capital Announces the Successful Exit of DVTEL

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Seacoast Capital Announces the Successful Exit of DVTEL

SAN FRANCISCO, CA--(Marketwired - Dec 18, 2015) - Seacoast Capital ("Seacoast") has announced the successful exit of its investment in DVTEL ("DVTEL" or the "Company") in conjunction with the $92 million sale of the Company to FLIR Systems. DVTEL is a leader in enterprise-class security and surveillance solutions, and develops and distributes integrated video management system (VMS) software, advanced video analytics software, visible and thermal security cameras, and related servers and encoders.

Tim Fay, Partner at Seacoast Capital commented: "DVTEL has a very talented management team which has done a terrific job building the foundation for significant growth. When we invested in DVTEL a little over eight months ago, we knew the management team would accomplish great things, but their performance has vastly exceeded our expectations." Yoav Stern, CEO of DVTEL added: "Seacoast has been a wonderful partner to work with. The capital Seacoast provided positioned us for growth and enabled us to unlock a great deal of value."

About DVTEL DVTEL, Inc. ( http://www.DVTEL.com ) DVTEL, Inc. is a world-class developer of open, scalable, end-to-end video surveillance solutions. Since 2003, the Company has evolved from a single product innovator of IP video management software ("VMS") to a global provider of high performance video surveillance software and hardware solutions including network video management systems, high-definition IP video surveillance cameras, encoders and decoders, and video analytics. The Company offers suites of products that are developed and tailored to meet the needs of enterprise-class end-users as well as mid-sized businesses and organizations all over the world.

About Seacoast Capital Seacoast Capital was founded in 1994 to make non-controlling junior capital investments (primarily subordinated debt and equity) in privately-held lower middle market companies. Seacoast specializes in "sponsorless" transactions, preferring to invest directly with company owners or management teams, although it will selectively consider investments led by professional investor groups. Seacoast typically provides between $3 million and $12 million of debt and equity capital for acquisitions, growth, shareholder buyouts, management buyouts, and leveraged recapitalizations. While industry agnostic, Seacoast broadly invests in the specialty manufacturing, value-added distribution, commercial services, environmental services, logistics and infrastructure services, health and wellness, and consumer sectors. Seacoast generally targets investments in companies with $10 million to $150 million in revenue and $2 million or more of EBITDA. With offices in Boston and San Francisco, Seacoast has invested over $300 million in over 20 states since 1994. Seacoast is currently investing its third fund, Seacoast Capital Partners III, L.P.

For more information, or to submit an investment opportunity to Seacoast, please contact Patrick Gengoux, Associate, by phone in San Francisco at (415) 956-1400 or via e-mail at pgengoux@seacoastcapital.com .

Contact: Patrick Gengoux Associate Tel: (415) 956-1400 E-Mail: Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ScriptSafe Revolutionizes Pharmacy Payment & Ad Certification

Updated Category News Views 4

Pharmacy Certification Made Easy When ScriptSafe rolled out its certification service for pharmacies, it felt like the industry's straitjacket was finally coming off. We’re talking about a process that traditionally took months, cost a small fortune, and made pharmacies fill out forms like they were honing a doctoral thesis. But now, you've got ScriptSafe offering a...

Continue Reading
Matchi Debuts Protein-Packed Matcha Lattes in Cans

Updated Category News Views 4

A New Twist on Protein Beverages Today, Matchi Global LLC is rolling out something new and bold: canned protein matcha lattes. It's not just another protein shake disguised in green robes. Oh no, this is a straight-up attempt to mesh pure ceremonial-grade matcha with a full 20 grams of complete filtered milk protein. And they’re delivering it all without any of those...

Continue Reading
Gun Violence Expo Aims for National Impact in Chicago

Updated Category News Views 5

Converging Minds at the Chicago Gun Violence Expo In a city known for its resilience amid diverse challenges, the National Gun Violence Prevention Expo is stepping into the spotlight. With all eyes on Chicago from September 24 to 26, this isn't just another event—it’s a clarion call for action. Uniting Influential Voices When you've got former NFL stars like Matt...

Continue Reading
Partners International Launches CareerPath for Youth

Updated Category News Views 7

A Fresh Start for Young Careers with CareerPath You remember the time in life when we thought just having a degree meant something? Well, the game’s changed, and now it’s a twisted jungle where young folks struggle to find their footing. Partners International, a name I’m no stranger to—known for their human capital wizardry—seems to have noticed this chaotic...

Continue Reading
ViewScan Unveils New AI Solution and Enhanced Site

Updated Category News Views 4

ViewScan's Latest Step in AI-Powered Monitoring Long Island's own ViewScan just kicked up some dust in the AI-based monitoring scene. This outfit is rolling out a new release of its ViewScan Protect software, fortified with advanced analytics aimed at beefing up security and operational efficiency. Now, before you gloss over this news as just another tech update, let me...

Continue Reading
Dr. Sarah Leary Leads CBTN's Growth in Pediatric Oncology

Updated Category News Views 4

Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...

Continue Reading
Handshake Introduces AI Skills Studio at NYSE Event

Updated Category News Views 6

Shaking Up the Job Market with AI Skills What's shaking things up this time around? Handshake's dramatic unveiling of its AI Skills Studio, that's what. While the world spins on its financial axis, Handshake's showing up with a toolkit that's not just geeky gobbledygook. They're dead set on prepping job seekers with the nitty-gritty of AI know-how hosted in a rather...

Continue Reading
Beemo, Choreo Forge AI Partnership for Wealth Management

Updated Category News Views 10

AI's New Role in Wealth Management Just when you think you've seen it all, along comes a partnership that shakes things up. Beemo Automation is teaming up with Choreo, a heavyweight in the tax-focused registered investment adviser world, to infuse some AI prowess where it matters. Choreographing their moves, they're looking to build something that's not just functional...

Continue Reading
2026 Beauty Icon Awards: Honoring Black Beauty Excellence

Updated Category News Views 7

When it comes to honoring legacy and future within the Black beauty industry, the 2026 Beauty Icon Awards seem ready to steal the spotlight. Set to take place on October 10th at Atlanta's Riverside EpiCenter, this gathering is more than just a fancy shindig – it's a tribute to Black beauty's massive influence on culture and commerce. Celebrating Pioneers and Innovators...

Continue Reading
Holland America Overhauls Half Moon Cay Offerings

Updated Category News Views 5

A Fresh Chapter for Half Moon Cay Mark it down, folks—Holland America Line is shaking things up over at RelaxAway, Half Moon Cay. The cruise line, known for its deep roots in premium cruising, is pouring resources into its private island playground to celebrate its 30th anniversary in 2027. And the timing couldn't be more calculated, what with peak cruise season around...

Continue Reading

Top 5 Most Recently Viewed Articles

How Nemolizumab and Lebrikizumab Are Shaping Atopic Dermatitis Care

Updated Category News Views 99

Transformative Changes in Atopic Dermatitis Treatments The field of dermatology, especially in relation to atopic dermatitis (AD), is experiencing significant transformations. Initially dominated by Sanofi/Regeneron's Dupixent, the landscape is evolving with the introduction of new treatments such as LEO Pharma's Adbry and Pfizer's Cibinqo. While Dupixent continues to...

Continue Reading
Roundhill Investments Updates Monthly Distributions for XPAY

Updated Category News Views 527

Overview of Roundhill Investments' ETF Distributions Roundhill Investments, a prominent ETF sponsor known for innovative financial solutions, has recently provided an update regarding its flagship product, the Roundhill S&P 500® Target 20 Managed Distribution ETF (XPAY). Announcing monthly distributions for the upcoming year, the company is setting an ambitious...

Continue Reading
THOR Industries Plans Engaging Investor Conference Participation

Updated Category News Views 259

Engaging Investor Conferences Ahead for THOR Industries THOR Industries, Inc. (NYSE: THO), a leading manufacturer in the recreational vehicle sector, has announced its participation in two important investor conferences. These events will provide an opportunity for management to connect directly with analysts and institutional investors. Key Details of the Upcoming...

Continue Reading
Oxford Partners Launches Healthcare Division with New Leadership

Updated Category News Views 113

Oxford Partners Launches Its Healthcare Division Oxford Partners, a prominent name in tenant and buyer representation, has recently made exciting strides by establishing its Healthcare Division. This initiative is highlighted by the appointment of Nelson Udstuen, who brings a wealth of experience to his new role as President of the Healthcare Division. Nelson Udstuen's...

Continue Reading
Transforming Cancer Diagnostics: The Rise of Fusion Biopsy

Updated Category News Views 297

Understanding the Fusion Biopsy Market Growth The fusion biopsy market is on the verge of significant growth, projected to reach USD 0.91 billion by 2029, with an impressive compound annual growth rate (CAGR) of 7.1%. This growth trajectory can be attributed to several critical factors, most notably the rising incidence of prostate cancer and the increasing awareness...

Continue Reading